Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Galena Biopharma GALE

Healthcare Biotechnology
"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

Recent & Breaking News (NDAQ:GALE)

Galena Biopharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

GlobeNewswire September 9, 2016

Galena Biopharma Reports Second Quarter 2016 Financial Results and Provides a Corporate Update

GlobeNewswire August 9, 2016

15 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  July 26, 2016

Galena Biopharma to Report Second Quarter 2016 Financial Results and Provide a Corporate Update on Tuesday, August 9, 2016

GlobeNewswire July 26, 2016

Galena Biopharma Announces Closing of Registered Direct Offering

GlobeNewswire July 13, 2016

10 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  July 8, 2016

Galena Biopharma to Host Webcast and Conference Call Today

GlobeNewswire July 8, 2016

Galena Biopharma Announces Pricing of Registered Direct Offering

GlobeNewswire July 8, 2016

4 Companies to Watch in July

PR Newswire June 30, 2016

Mid-Afternoon Market Update: Dow Jumps Over 250 Points; Diamond Resorts Shares Climb Following Apollo Deal

Benzinga.com  June 29, 2016

7 Biggest Mid-Day Losers For Wednesday

Benzinga.com  June 29, 2016

Citi Favors General Growth Properties Defensive Strategy, Reaffirms Buy

Benzinga.com  June 29, 2016

Mid-Day Market Update: Crude Oil Surges 3%; Galena Biopharma Shares Tumble

Benzinga.com  June 29, 2016

Stocks Hitting 52-Week Lows

Benzinga.com  June 29, 2016

Mid-Morning Market Update: Markets Open Higher; General Mills Profit Tops Expectations

Benzinga.com  June 29, 2016

Galena Biopharma Plunges 80% Amid Discontinued NeuVax Phase 3, PRESENT Interim Analysis

Benzinga.com  June 29, 2016

Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase 3, PRESENT Interim Analysis based on Independent Data Monitoring Committee Recommendation

GlobeNewswire June 29, 2016

Biotechnology Stocks Under Review - Eleven Biotherapeutics, Relypsa, Galena Biopharma, and Amgen

PR Newswire June 20, 2016

Galena Biopharma Presents GALE-401 Combined Safety Data at the European Hematology Association 21st Congress

GlobeNewswire June 13, 2016

Galena Biopharma Receives Two Orphan Drug Designations for GALE-301 and GALE-301/GALE-302

GlobeNewswire June 10, 2016